Browsing category:

Patent Expiration 2017


Butoconazole Nitrate, CAS number 64872-77-1 is also known as the brand name GYNAZOLE-1. Marketed by Ther-Rx Corporation, the patent for this vaginal cream expires November 17, 2017. Indicated for the treatment of vulvovaginal candidiasis, or infections caused by Candida, butoconazole is available in a 2% strength cream. Statistically Candida, or yeast infections, are extremely common.[…]

Read More

Ciclesonide is a corticosteroid nasal spray, which is also known as the brand name Omnaris. With the patent for Omnaris due to expire on October 24, 2017, development for a generic product is sure to be underway. Ciclesonide works by preventing the release of substances in the body that cause inflammation, making this medication an[…]

Read More

The World Health Organization has predicted over 20 million new cancer cases in 2015 worldwide. This seemingly unbelievable number is not only astonishing; it is also a dire warning from the WHO. With the future onslaught of patients needing cancer care and treatments, the WHO has been urging researchers to continue to develop new products[…]

Read More

Drospirenone is a key ingredient alongside Estradiol in the birth control pill Angeliq. The patent for Angeliq expires on August 11, 2017, making way for the development of generic options of this versatile hormone regulating medication. Developed as a birth control medication, used to prevent pregnancy, Angeliq works by preventing ovulation and causing changes in[…]

Read More

Known as the brand name Lotrel, Amlodipine Besylate plays an integral part of this powerful calcium channel blocker. Lotrel, which is marketed by Novartis, is a combination of amlodipine besylate and benazepril. The patent for this formidable medication expires on December 19, 2017, paving the way for a generic version of this blockbuster drug. With[…]

Read More

With the patent for Clobex (clobetasol propionate) facing an expiration of September 22, 2017, this prescription medication used to treat adults and children 12 years and older with psoriasis is sure to have generic development. Clobetasol propionate is available as a topical steroid spray, and it is effectual as it decreases inflammation and suppresses an[…]

Read More

The microbiology of Bacterial Vaginosis represents a complex change in the vaginal flora, which is characterized by a reduction in the concentration of the normally dominant hydrogen-peroxide producing lactobacilli, as well as an increase in concentration of other organisms, particularly anaerobic gram negative rods. The administration of clindamycin¬†administered either orally or intravaginally has proven effectual[…]

Read More

The expiration for the patent of the new formulation of Prozac, also known as the generic drug Fluoxetine Hydrochloride, is slated for November 1, 2017. As a common and effectual antidepressant, Fluoxetine HCl CAS# 56296-78-7, has proven to be a valuable treatment for patients in the United States and worldwide. In fact, antidepressant use in[…]

Read More

Atazanavir Sulfate, CAS No: 229975-97-7 is also known as the antiretroviral medication Reyataz. With the patent for Reyataz expiring on June 20, 2017 research and development teams are currently working on the development of a generic version of this vital drug. Indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection, atazanavir[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service